Midtown Specialty RX
Outcome
DEA revoked DEA Certificate of Registration No. FM2396427 effective November 12, 2024, after finding the pharmacy dispensed controlled substances over 18 months with no regard for red flags, failed to maintain proper inventories, and had the owner transporting and storing controlled substances at a personal residence.
Details
Midtown Specialty RX — DEA Revocation for Red Flag Failures and Residential Storage (2022–2024)
Outcome: DEA Administrator Anne Milgram signed a Decision and Order on October 4, 2024, revoking Midtown Specialty RX's DEA Certificate of Registration No. FM2396427 effective November 12, 2024, after finding that the Houston, Texas pharmacy dispensed controlled substances over an 18-month period without regard for red flags, failed to maintain proper inventories, failed to properly store controlled substances at its registered location, and had the owner transporting and storing controlled substances at a personal residence.
Midtown Specialty RX was a pharmacy located in Houston, Texas. DEA investigation revealed multiple simultaneous categories of violations occurring over approximately 18 months. First, the pharmacy dispensed many controlled substances without any regard for its obligations to identify, resolve, or document blatant red flags of potential diversion — a foundational failure of the corresponding responsibility pharmacists hold under the Controlled Substances Act.
Second, the pharmacy failed to maintain proper controlled substance inventories, undermining the ability to account for the chain of custody and disposition of controlled substances. Third, the pharmacy failed to properly store controlled substances at its registered DEA location. Most egregiously, the pharmacy's owner was transporting and storing controlled substances at a personal residence — in complete disregard of the DEA's security requirements, which require registered storage facilities that are physically secured and registered with DEA.
The DEA revoked the Certificate of Registration, denied pending renewal and modification applications, and denied any other pending applications for additional DEA registration in Texas. The order became effective November 12, 2024.
Primary Source: Midtown Specialty RX; Decision and Order (Fed. Reg. Oct. 10, 2024)
How Crucible Prevents This
Midtown Specialty RX exhibited four simultaneous violation categories: red flag failures, inventory deficiencies, improper storage, and controlled substances transported to a personal residence. Crucible's multi-layered compliance framework — red-flag dispensing controls, biennial inventory tracking, storage location monitoring, and DEA registration address cross-referencing — would have detected each of these violations independently.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works